Skip to main content
PMC home page
Frontiers in Physiology logoLink to Frontiers in Physiology
. 2021 May 7;12:654797. doi: 10.3389/fphys.2021.654797

Gender Difference in Chronic Cough: Are Women More Likely to Cough?

Haodong Bai 1,†, Bingxian Sha 1,†, Xianghuai Xu 1,*, Li Yu 1,*
PMCID: PMC8138462  PMID: 34025449

Abstract

Chronic cough is a common complaint for patients to seek medical cares all over the world. Worldwide, about two thirds of chronic cough patients are females. However, in some regions of China the prevalence of chronic cough between sexes is roughly the same. Estrogen and progesterone can not only have an effect on transient receptor potential vanilloid 1 channel, eosinophils and mast cells, but also influence laryngeal dysfunction, gastroesophageal reflux disease and obstructive sleep apnea hypopnea syndrome, which may lead to increased cough sensitivity in women. On the other hand, the quality of life was adversely affected more in female patients with chronic cough. Both hormones possibly cause gender difference in chronic cough.

Keywords: chronic cough, gender difference, estrogen, progesterone, sex hormone

Introduction

Chronic cough is defined as cough lasting no less than 8 weeks. In non-smoker patients not taking protussive drugs and with a normal chest radiograph, the common causes of chronic cough are asthma syndromes (including cough variant asthma and eosinophilic bronchitis), upper airway cough syndrome/postnasal drip syndrome, gastroesophageal reflux-related chronic cough, and atopic cough (Chinese Medical Association of Respiratory Disease Asthma Study Group, 2016). Chronic cough has been one of the main complaints of patients to seek medical cares, which negatively affects the quality of life and its treatment has been a great challenge in clinical practice (Ma et al., 2009; Young and Smith, 2010; Song et al., 2015). In recent years, a gender difference was found in chronic cough. Most studies showed that it was more common in women, and that it was more common in middle-aged and elderly women with refractory chronic cough or unexplained chronic cough (Morice et al., 2014; Yu et al., 2016; Kang et al., 2019). If the mechanism of gender difference could be clarified, it may provide new ideas for the treatment of chronic cough, especially refractory cough, in the future. This article reviews the status of gender difference in chronic cough and possible reasons for it.

Status of Gender Difference in Chronic Cough

In Europe and America, there is a significant gender difference in patients with chronic cough, a number of studies have shown that the ratio of female to male is 1.86–2.76:1 (French et al., 2005; Kelsall et al., 2009; Morice et al., 2014; Hartley et al., 2015; Campi et al., 2020). In some Asian countries, such as Japan and South Korea, similar results have also been obtained (Niimi et al., 2013; Song et al., 2014; Kang et al., 2019). But in China, it differs in different regions. Studies in Shanghai (Ma et al., 2009; Yu et al., 2009; Ding et al., 2019) and Chongqing (Cao et al., 2009) showed that the proportion of females can reach 60% or more in chronic cough patients, which is consistent with the data of Europe and America, while patients with chronic cough have a roughly equal sex distribution in Guangzhou (Deng et al., 2016; Lai et al., 2019), Lanzhou (Liu et al., 2016), and Beijing (Liu and Lin, 2009). In a national-wide multi-center study, except for a eastern region (Shanghai), chronic cough patients presented an approximately equal gender distribution in western, southern, northern, and northeastern regions of China (Lai et al., 2013; Lai and Long, 2020). What’s more, a female predominance among patients with refractory or unexplained chronic cough has been reported (Ryan et al., 2012; Muccino et al., 2020; Smith et al., 2020) (more specific details about sex distribution are shown in Table 1).

TABLE 1.

Sex distribution of patients with chronic cough.

Author/year Region Number Female:Male Average age (x¯± S)
Morice et al., 2014 multi-center 10032 1.92:1 55 ± 14.97
Muccino et al., 2020 multi-center 1314 2.90:1 58.1 ± 12.1
Campi et al., 2020 Italy 1204 2.37:1 61
Smith et al., 2020 United States, United Kingdom 253 3.21:1 60.2 ± 9.9
French et al., 2005 United States 172 2.07:1 53.6
Hartley et al., 2015 United States 128 2.76:1 55.39 ± 13.54
Kelsall et al., 2009 United Kingdom 100 1.86:1 55.8 ± 11
Ryan et al., 2012 Australia 62 1.82:1 61.8
Ding et al., 2019 China (Shanghai) 1311 1.70:1 47.3 ± 15
Ma et al., 2009 China (Shanghai) 110 2.06:1 47 ± 14
Yu et al., 2009 China (Shanghai) 940 1.62:1 49 ± 16
Lai et al., 2019 China (Guangzhou) 1822 1.06:1 43 ± 13.7
Lai et al., 2013 China 704 1.23:1 40.4 ± 12.8
Liu et al., 2016 China (Lanzhou) 173 0.92:1 42 ± 14
Cao et al., 2009 China (Chongqing) 233 1.40:1 44.5
Liu and Lin, 2009 China (Beijing) 103 0.81:1 38 ± 15
Deng et al., 2016 China (Guangzhou) 96 0.96:1 35.4 ± 9.9
Niimi et al., 2013 Japan 313 1.48:1 51.8 ± 18.9
Kang et al., 2019 South Korea 447 1.92:1 54.4 ± 15.9
Song et al., 2014 South Korea 272 2.24:1 52.8 ± 15.7
Open in a new tab

Possible Reasons for Gender Difference in Chronic Cough

The gender difference in chronic cough may be related to the increased cough sensitivity in women and more negative impacts on the quality of life in female patients.

Increased Cough Sensitivity in Women

Cough sensitivity is defined as the reaction intensity of cough reflex to different stimuli. Patients with chronic cough commonly have a clinical characteristic of increased cough reflex sensitivity. Morice (2010) raised a concept of cough hypersensitivity syndrome, defined as a disease with chronic cough as the only or prominent symptom. A number of studies have shown the cough sensitivity of patients with chronic cough is higher than that of healthy people. Both in patients with chronic cough and healthy people, the cough sensitivity of women is higher than that of men (Dicpinigaitis and Rauf, 1998; Kastelik et al., 2002; Song et al., 2014; Lai et al., 2019). Elderly females tend to have higher cough sensitivity (Song et al., 2014; Lai et al., 2019). In the study of Fujimura, among 40 middle-aged females, capsaicin cough threshold in 24 premenopausal subjects was significantly greater than that in postmenopausal subjects (Fujimura et al., 1996).

Cough receptors are nerve endings existing in the tracheal and bronchial epithelial cells and in the basal layer of the epithelium. There are two types. The myelinated Aδ-fiber is sensitive to mechanical stimulus and acid. The main role of Aδ-driven cough is to prevent the aspiration of foreign bodies or reflux. The other one is unmyelinated C-fiber, which is sensitive to chemical substances such as capsaicin and endogenous mediators (Shi and Qiu, 2007; Kavalcikova-Bogdanova et al., 2016). The ability to sense chemical substances of C-fiber depends on the expression of different ion channels. Transient receptor potential vanilloid 1 (TRPV1) is one of them and known as capsaicin receptor, capsaicin and various inflammatory mediators could activate C-fiber through TRPV1. The expression of TRPV1 is increased in the airway of patients with chronic cough (Mitchell et al., 2005), which may be the basis of increased cough sensitivity in such patients. Similar to TRPV1, the main stimulants of transient receptor potential ankyrin 1 (TRPA1) include acrolein, cinnamaldehyde, cold air (<17°C), motor vehicle exhaust and cigarette smoke. Compared with healthy subjects, patients with chronic refractory cough have increased cough sensitivity to allyl isothiocyanate (TRPA1 receptor agonist) and capsaicin. Whether in patients with chronic cough or in healthy subjects, women have more obvious AITC and capsaicin cough sensitivity than men (Long et al., 2019). Purinergic receptor P2X3 is an ATP-gated ion channel which exists in peripheral sensory nerves including the vagal afferent neurons that innervate the cough reflex. A randomized, double-blind, placebo-controlled study from Abdulqawi et al. (2015) showed that P2X3 receptor antagonist could reduce cough frequency of the refractory chronic cough patients. In their opinion, P2X3 receptors seem to have a key role in mediation of cough neuronal hypersensitivity (Abdulqawi et al., 2015).

Effects of Estrogen and Progesterone on Cough Sensitivity

The influence of sex hormones on ion channels has been followed for a long time. Estrogen influences TRPV1 activation/sensitization, leading to increased channel excitability (Patberg, 2011; Kavalcikova-Bogdanova et al., 2016), 17β-estradiol can stimulate the expression and release of prolactin, which increases phosphorylation of TRPV1 (Xu et al., 2008). There are some preclinical studies supporting this point. In the research of Pohóczky et al. (2016), the mRNA expression of TRPV1 and TRPA1 in rat endometrium increases significantly after the treatment of diethylstilbestrol, which is a non-selective estrogen receptor agonist. However, no significant change was observed in TRPV1 and TRPA1 expression after combining diethylstilbestrol with progesterone (Pohóczky et al., 2016). Peng et al. (2008) found that the estrus cycle is closely related to activation of TRPV1 channel in pelvic nerves of rats, activation of C-fibers by capsaicin is significantly greater in pro-estrus phase (high level of estradiol and low level of progesterone) than in the metestrus phase (low level of estradiol and high level of progesterone), suggesting estradiol as a hormonal mediator for TRPV1 (Peng et al., 2008). Kiasalari et al. (2010) study showed more than 75% of HE TRPV1 cells express estrogen receptor α in the ganglion of lumbar and sacral regions, suggesting a possible modulating effect of estrogen.

However, this estrogen hypothesis cannot explain the hypersensitive cough in postmenopausal women, who typically have a lack of estrogen. In addition, it was recognized that the activation of TRPV1 by capsaicin can be inhibited by a nonclassical estrogen-signaling pathway (Xu et al., 2008), so it can be speculated that the decrease of estrogen level in postmenopausal women weakens this inhibitory effect and may lead to increased cough sensitivity in middle-aged and elderly women. A study on pain showed that the effect of estrogen on cultured dorsal root ganglion neurons could decrease the expression of P2X3 receptor in both mRNA and protein levels (Ma et al., 2011), suggesting a protective effect of estrogen.

As for clinical studies, Kavalcikova-Bogdanova et al. (2018) conducted a study in healthy women and women taking oral contraceptive pills to analyze the relationship between sex hormones and cough sensitivity during different phases of menstrual cycle. The study showed that capsaicin cough sensitivity is influenced by the level of female sex hormones. Compared with follicular phase, the capsaicin cough sensitivity is higher in luteal phase. And they revealed the correlation between cough sensitivity and the ratio progesterone/estrogen rather than estrogen alone. The progesterone/estrogen ratio is high in luteal phase due to elevation of progesterone and decrease of estrogen. Menopause is characterized by the lack of estrogen, similarly to luteal phase, which may explain increased cough sensitivity in postmenopausal women.

Effects of Estrogen on Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) is a heterogeneous, multi−symptom disease, which is categorized into reflux esophagitis (RE) and non-erosive reflux disease according to endoscopy. In the study for subjects without reflux symptoms or GERD observed by ambulatory 24-h esophageal pH monitoring, women have significantly fewer reflux events at both esophageal measuring spots, and less total reflux time and percentage of time with pH < 4 in the distal esophagus than men (Vega et al., 2013). Epidemiologic studies have indicated that RE is more common in men, while nonerosive reflux disease is more common in women (Asanuma et al., 2016; Kim et al., 2016). The severity and prevalence of GERD seem to be closely related to the reproductive hormone of women, the prevalence of the GERD rises rapidly during the postmenopausal period (Kim et al., 2016). Some studies have shown the incidence of RE increased with age. In addition, old women showed more severe RE than older men, the incidence of severe RE increased higher in postmenopausal women (Furukawa et al., 1999; Menon et al., 2011). It has been revealed that estrogen contributes to tissue resistance in female animal models via anti-inflammatory activity. Masaka et al. (2013) demonstrated that estrogen attenuates RE by inactivating mast cells, using a rat model of surgically induced RE. Moreover, esophageal tissue damage in males and ovariectomized rats was attenuated by exogenous 17β-estradiol through weakening mast cell-mediated cytotoxicity and reducing the production of cytokines, especially TNF-α which drives inflammation. And estrogen has been shown to enhance cutaneous wound healing via inactivating macrophages, so anti-inflammatory functions of estrogen may contribute to the gender difference in the incidence of RE (Ashcroft et al., 2003; Gilliver et al., 2011). Reduced levels of estrogen can potentially lead to increased inflammation/immune activation (Grishina et al., 2014) and declining tissue resistance, estrogen in young women may be responsible for GERD being more common in men and postmenopausal women. GERD is also an important cause of chronic cough (Wang et al., 2010; Morice, 2013), so it may be one of the reasons why women, especially elderly women, are prone to cough.

Progesterone and Laryngeal Dysfunction

Bucca et al. found that an irritable larynx was very common among patients who presented with chronic cough as the main symptom. Laryngeal hyperresponsiveness was found in more than 2/3 of patients with chronic cough due to perennial rhinitis/chronic rhinosinusitis, GERD and unknown causes (Bucca et al., 2011). Randomized trials found that the speech therapy which ameliorates laryngeal dysfunction is also effective in patients with chronic cough, suggesting a potential connection between laryngeal dysfunction and chronic cough (Gibson and Vertigan, 2009; Ryan et al., 2009). The gender difference in patients with chronic cough caused by laryngeal dysfunction is still unclear, and further studies are needed to confirm it. Increased concentration of progesterone could rise laryngeal edema and venous dilatation. It may activate the rapidly adapting receptors in airways, which are highly sensitive to the changes of pulmonary extravascular space. Activation of rapidly adapting receptors ensues respiratory stimulation and cough (Kavalcikova-Bogdanova et al., 2016, 2018).

Effects of Estrogen and Progesterone on Inflammation

The increased cough sensitivity of patients with chronic cough is closely related to the increased expression and activation of TRPV-1 in airway epithelial nerves (Chuang et al., 2001). Airway inflammation in patients with chronic cough is caused by infiltration of inflammatory cells such as eosinophils, neutrophils, and lymphocytes (Grabowski et al., 2013), which sensitizes TRPV-1 receptors by releasing relevant inflammatory mediators, including bradykinin and lipoxygenase metabolites of arachidonic acid (Chuang et al., 2001; Ricciardolo, 2001; Morice and Geppetti, 2004). At the same time, airway inflammation increases the level of protons, neurotransmitters, and growth factors in the local environment (Morice and Geppetti, 2004), such as brain-derived neurotrophic factor and bradykinin, which induce thermal response and contribute to the activation of TRPV-1 (Woolf and Salter, 2000). In addition, a related study has shown that the mechanical stress on the airway from severe air flow caused by cough could lead to the mechanical injury to airway (Irwin, 2006), resulting in the shedding of airway mucosal epithelium, goblet cells and squamous cells metaplasia, and infiltration of lymphocytes and plasma cells (Irwin et al., 2006). Besides, changes in the airway pressure caused by cough could lead to enhanced the interaction between white blood cells and endothelium in the trachea and the recruitment of white blood cells by affecting tracheal vascular endothelium (Lim and Wagner, 2003). It was documented that estrogen and progesterone receptors are expressed in mouse, rat and human mast cells (Jensen-Jarolim and Untersmayr, 2008), β-estradiol significantly enhanced the eosinophil adhesion to human mucosal microvascular endothelial cells, and eosinophils stimulated by a combination of β-estradiol and progesterone showed significantly induced degranulation (Hamano et al., 1998b), estradiol and progesterone can also activate mast cells. Hamano et al. (1998a) found that estradiol and progesterone increased the expression of H1 receptors in human nasal epithelial cells and microvascular endothelial cells leading to enhanced nasal hyperreactivity. Bowser and Riederer (2001) believed that progesterone may affect fibroblasts and extracellular matrix in the nasal mucosa of pregnant women, and estrogen and progesterone can change the concentration of neurotransmitter P, leading to nasal congestion and other symptoms. Postnasal drip from nasal diseases is one of the causes of chronic cough (Chinese Medical Association of Respiratory Disease Asthma Study Group, 2016). The effect of estrogen and progesterone on allergic mediators such as eosinophils, mast cells, histamine, and the inflammatory mediators affect may be one of the possible mechanisms of increased cough sensitivity in women. However, we have also noted that late-onset asthma often present with eosinophilic inflammation more frequently in men than women (de Groot et al., 2016). Some asthma cluster analyses have mentioned a higher proportion of men with late-onset asthma mainly characterized by eosinophilic inflammation and fewer symptoms (Haldar et al., 2008), but no corresponding gender difference has been observed in other studies of related asthma cluster analyses on late-onset asthma patients (Moore et al., 2010; Lefaudeux et al., 2017), suggesting that female hormones do not necessarily cause more inflammation than men. Therefore, the above speculation needs to be confirmed by more rigorous basic research.

Obstructive Sleep Apnea Hypopnea Syndrome and Cough Sensitivity

More attention has been paid to the relationship between obstructive sleep apnea (OSA) and chronic cough. It was documented that cough sensitivity to capsaicin increased in obstructive sleep apnea hypopnea syndrome patients (Shi et al., 2019). Obstructive sleep apnea hypopnea syndrome is one of the causes of chronic cough. Gastroesophageal reflux, postnasal drip and airway inflammation are possible mechanisms of chronic cough induced by OSA (Liang et al., 2012). Epidemiologic studies showed that, OSA was two to three times more prevalent in men than in women before age 50, while the prevalence of OSA increased in postmenopausal women, who are 3 times more likely to have OSA compared to before. The risk of OSA also increased in women during pregnancy or with polycystic ovarian syndrome (Galvan et al., 2017). Lower levels of estradiol might contribute to the increased prevalence of OSA during the menopause transition and early postmenopause. There are studies demonstrating an inverse relationship between estradiol and OSA, which is indirectly suggested by reports that postmenopausal women using hormone therapy have a lower prevalence of OSA than those not taking hormone therapy (Bixler et al., 2001; Shahar et al., 2003; Galvan et al., 2017). OSA may be one of the reasons for increased cough sensitivity in postmenopausal women.

Central Neural Circuits Regulating Cough

Sterusky et al. (2020) have found that female guinea pigs respond the same way to the commonly used tussive agents (capsaicin, distilled water, allyl isothiocyanate, cinnamaldehyde, and citric acid) as male guinea pigs, no obvious differences in cough count and cough latency were observed between female and male guinea pigs. In their opinion, there is not any huge difference in peripheral sensory pathways of cough between humans and guinea pigs, so something different may exist in the central neural circuits regulating cough, which may be responsible for the gender difference of chronic cough in human. Morice et al. (2014) also found that females were more sensitive to capsaicin challenge, when got lower stimulus, the magnitude of the activation in the somatosensory cortex of females was approximately twice that of males in fMRI, the preponderance of females in chronic cough may be explained by sex-related differences in the central processing of cough sensation. At present, the explanation for possible gender differences in cough sensitivity of central sensitization is limited, but we can learn from research about pain. Both chronic cough and chronic pain are mediated by unmyelinated C and myelinated Aδ sensory fibers (Bolser et al., 2006), exhibiting a similar neurobiological properties (O’Neill et al., 2013). They are regulated by cerebral cortical activity (Mazzone et al., 2013). Women are more sensitive to and less tolerant to pain than men (Sorge and Totsch, 2017). In addition, women are more sensitive to central sensitivity than men, showing an enhanced response of nociceptors to normal or subthreshold harm inputs (Smith et al., 2019). However, few studies have been conducted to explore the mechanism of gender differences in central sensitization of chronic cough. Thus, further studies are needed. One other reason why there was no gender bias in the cough of guinea pigs, might be the guinea pigs in the research were just 7 weeks old. The average lifespan of guinea pigs is 4–5 years, and female guinea pigs typically begin to develop follicles at 14 days and ovulate at about 60 days, the 7-week-old guinea pigs have not yet reached middle age and were not significantly affected by sex hormones, so there was no sex difference in cough of guinea pigs.

Impaired Cough Suppression

Recent studies have shown that impaired cough suppression may be one of the reasons why symptoms in chronic cough patients cannot be controlled. Cho and Hilton et al. (2020) revealed that patients with refractory chronic cough were less able to voluntarily suppress capsaicin or other noxious stimuli-evoked cough compared to healthy controls (Cho et al., 2019). In functional brain imaging study involving patients with refractory chronic cough, Mazzone (2019) found a reduced level of activity in component regions of their cough suppression network in the inability of patients to suppress cough. Whether there is any gender difference in cough suppression is unclear, which needs to be further investigated.

The Quality of Life in Female Patients With Chronic Cough Decreased Significantly

Chronic cough has negative effects on health-related quality of life (HRQOL) of patients in many aspects including physical, psychological, and social domains (Ma and Qiu, 2008; Ma et al., 2009). For most patients with chronic cough, the main reason for seeking medical attention is often a serious decline in the quality of life (Yang et al., 2010). Won et al. (2020) investigated the relationship between chronic cough and HRQOL using the 3-level EuroQoL 5-dimension component index score. They found that chronic cough was obviously associated with HRQOL among adults more than 40 years old, the overall 3-level EuroQoL 5-dimension component index score was significantly lower in patients with chronic cough, and chronic cough had a greater impact on HRQOL in women more than 65 years old (Won et al., 2020). Our previous study showed that several adverse events including embarrassment, frustration and sleep disorder were more apparent in women than men as measured with Leicester cough questionnaire although there was no confirmed gender difference in overall HRQOL of patients with chronic cough (Ma et al., 2009). Due to the different characteristics of physiological structure, stress urinary incontinence is more prevalent in women than men. It was reported that more than 50% of female patients suffered from stress urinary incontinence due to chronic cough, while the proportion of male patients is far lower (Yang et al., 2010). The discomfort, embarrassment and anxiety caused by urinary incontinence can limit women’s social activities and seriously affect their quality of life. The serious decline in quality of life leads to a higher rate of female patients seeking medical attention, females are more likely to refer to specialist clinics than males due to stronger perception of discomfort, which is also an important reason for the gender difference of chronic cough.

Possible Explanation for a Roughly Equal Sex Distribution in Some Regions

As mentioned above, there are regional differences in the gender distribution of chronic cough patients in China. The reason has not yet been clearly explained, which may be related to the different patients enrolled in various studies and different healthcare systems.

Age difference: In Table 1, the average age of the patients with chronic cough is over 51 in occident, Japan and South Korea, from 44.5 to 49 in Shanghai and Chongqing, and 35–43 in Guangzhou, Lanzhou and Beijing. That is to say, patients in the studies that have a roughly equal sex distribution are younger. Cough sensitivity is generally higher in females, especially in elderly females (Song et al., 2014). A roughly equal sex distribution in studies of Guangzhou and other places may be due to the younger age of enrolled patients.

Exclusion criteria difference: Smoking is an important risk factor for chronic cough (Çolak et al., 2017). Current smokers or ex-smokers who stopped smoking less than 2 years before the first visit to the clinic were excluded from our studies (Ma et al., 2009; Yu et al., 2009; Ding et al., 2019), while smokers were not excluded or ex-smokers who stopped smoking only less than 6 months were excluded in some studies (Lai et al., 2013, 2019). There are more male smokers in China, which may have an impact on the results of studies and cause regional differences in the gender distribution.

Healthcare system difference: In Europe and America, patients need strict referral from family doctors and general practice before going to specialist clinics. However, patients in China can freely choose hospitals for treatment and go directly to specialist clinics. Therefore, the data used in Chinese studies were close to general population in some degree, while general population studies did not find a consistent female predominance in chronic cough (Chen et al., 2006). It may be one of the reasons for a roughly equal sex distribution in some regions of China.

As for climate and occupation, there is a lack of multicenter investigations studying the influence of climate and occupation on gender distribution of chronic cough patients in China. Further investigations are needed to clarify it.

Conclusion

The gender difference is an important characteristic of chronic cough. Most studies show that it is more common in women, and the same as refractory/idiopathic chronic cough. Estrogen and progesterone can not only have an effect on TRPV1 channel, eosinophils and mast cells, but also influence laryngeal dysfunction, GERD, and obstructive sleep apnea hypopnea syndrome, which may lead to the increased cough sensitivity in women. And the quality of lives was adversely affected more in female patients. Increased cough sensitivity in women and more negative impacts on the quality of lives in female patients are possible reasons for the gender difference in chronic cough. The regional differences in the gender distribution of chronic cough patients in China may be related to the different patients enrolled in various studies. In the future, more studies are needed to determine the specific mechanisms leading to gender difference of chronic cough, which may provide new ideas and targets for the treatment of refractory cough (the main content is summarized in Figure 1).

FIGURE 1.

FIGURE 1

Open in a new tab

Female predominance among cough patients.

Author Contributions

XX and LY conceived and critically reviewed the structure of the manuscript. HB drafted and revised the manuscript. HB and BS collected the literatures and completed the tables. All authors read and approved the final manuscript.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Abbreviations

TRPV1

transient receptor potential vanilloid 1

GERD

gastroesophageal reflux disease

TRPA1

transient receptor potential ankyrin 1

RE

reflux esophagitis

OSA

obstructive sleep apnea

HRQOL

health-related quality of life.

Footnotes

Funding. This study was supported by the National Natural Science Foundation of China (Nos. 82070102 and 81770097), the Project of Science and Technology Commission of Shanghai Municipality (No. 20ZR1451500), and the Fund of Shanghai Youth Talent Support Program, the Fund of Shanghai Municipal Health Commission for Excellent Young Scholars (No. 2018YQ01).

References

  1. Abdulqawi R., Dockry R., Holt K., Layton G., McCarthy B. G., Ford A. P., et al. (2015). P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study. Lancet 385 1198–1205. 10.1016/s0140-6736(14)61255-1 [DOI] [PubMed] [Google Scholar]
  2. Asanuma K., Iijima K., Shimosegawa T. (2016). Gender difference in gastro-esophageal reflux diseases. World J. Gastroenterol. 22 1800–1810. 10.3748/wjg.v22.i5.1800 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ashcroft G. S., Mills S. J., Lei K., Gibbons L., Jeong M. J., Taniguchi M., et al. (2003). Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. J. Clin. Invest. 111 1309–1318. 10.1172/jci16288 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bixler E. O., Vgontzas A. N., Lin H. M., Ten Have T., Rein J., Vela-Bueno A., et al. (2001). Prevalence of sleep-disordered breathing in women: effects of gender. Am. J. Respir. Crit. Care Med. 163(3 Pt 1) 608–613. [DOI] [PubMed] [Google Scholar]
  5. Bolser D. C., Poliacek I., Jakus J., Fuller D. D., Davenport P. W. (2006). Neurogenesis of cough, other airway defensive behaviors and breathing: a holarchical system? Respir. Physiol. Neurobiol. 152 255–265. 10.1016/j.resp.2006.01.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bowser C., Riederer A. (2001). Detection of progesterone receptors in connective tissue cells of the lower nasal turbinates in women. Laryngorhinootologie 80 182–186. [DOI] [PubMed] [Google Scholar]
  7. Bucca C. B., Bugiani M., Culla B., Guida G., Heffler E., Mietta S., et al. (2011). Chronic cough and irritable larynx. J. Allergy Clin. Immunol. 127 412–419. 10.1016/j.jaci.2010.10.038 [DOI] [PubMed] [Google Scholar]
  8. Campi G., Noale M., Fabbrizzi A., Lavorini F., Maggi S., Fontana G. (2020). The demographic and clinical characteristics of an Italian population of adult outpatients with chronic cough. Aging Clin. Exp. Res. 32 741–746. 10.1007/s40520-019-01464-4 [DOI] [PubMed] [Google Scholar]
  9. Cao G., Chen X., Dai X., Xiong W., Chen H., Su Y., et al. (2009). A multi-center study on clinical and etiological diagnosis of chronic cough in Chongqing City. Chin. J. Respir. Crit. Care Med. 8 565–568. [Google Scholar]
  10. Chen R., Lai K., Liu C., Luo W., Zhong N. (2006). An epidemiologic study of cough in young college students in Guangzhou. Chin. J. Epidemiol. 27 123–126. [PubMed] [Google Scholar]
  11. Chinese Medical Association of Respiratory Disease Asthma Study Group (2016). Guidelines for the diagnosis and treatment of coughing (2015). Chin. J. Tuberc. Respir. Dis. 39 323–354. [Google Scholar]
  12. Cho P. S. P., Fletcher H. V., Turner R. D., Jolley C. J., Birring S. S. (2019). Impaired cough suppression in chronic refractory cough. Eur. Respir. J. 53:1802203. 10.1183/13993003.02203-2018 [DOI] [PubMed] [Google Scholar]
  13. Chuang H. H., Prescott E. D., Kong H., Shields S., Jordt S. E., Basbaum A. I., et al. (2001). Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 411 957–962. 10.1038/35082088 [DOI] [PubMed] [Google Scholar]
  14. Çolak Y., Nordestgaard B. G., Laursen L. C., Afzal S., Lange P., Dahl M. (2017). Risk factors for chronic cough among 14,669 individuals from the general population. Chest 152 563–573. 10.1016/j.chest.2017.05.038 [DOI] [PubMed] [Google Scholar]
  15. de Groot J. C., Storm H., Amelink M., de Nijs S. B., Eichhorn E., Reitsma B. H., et al. (2016). Clinical profile of patients with adult-onset eosinophilic asthma. ERJ Open Res. 2 00100–2015. 10.1183/23120541.00100-2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Deng H. Y., Luo W., Zhang M., Xie J. X., Fang Z. Y., Lai K. F. (2016). Initial empirical treatment based on clinical feature of chronic cough. Clin. Respir. J. 10 622–630. 10.1111/crj.12270 [DOI] [PubMed] [Google Scholar]
  17. Dicpinigaitis P. V., Rauf K. (1998). The influence of gender on cough reflex sensitivity. Chest 113 1319–1321. 10.1378/chest.113.5.1319 [DOI] [PubMed] [Google Scholar]
  18. Ding H., Xu X., Wen S., Yu Y., Pan J., Shi C., et al. (2019). Changing etiological frequency of chronic cough in a tertiary hospital in Shanghai, China. J. Thorac. Dis. 11 3482–3489. 10.21037/jtd.2019.07.86 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. French C. T., Fletcher K. E., Irwin R. S. (2005). A comparison of gender differences in health-related quality of life in acute and chronic coughers. Chest 127 1991–1998. 10.1378/chest.127.6.1991 [DOI] [PubMed] [Google Scholar]
  20. Fujimura M., Kasahara K., Kamio Y., Naruse M., Hashimoto T., Matsuda T. (1996). Female gender as a determinant of cough threshold to inhaled capsaicin. Eur. Respir. J. 9 1624–1626. 10.1183/09031936.96.09081624 [DOI] [PubMed] [Google Scholar]
  21. Furukawa N., Iwakiri R., Koyama T., Okamoto K., Yoshida T., Kashiwagi Y., et al. (1999). Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy. J. Gastroenterol. 34 441–444. 10.1007/s005350050293 [DOI] [PubMed] [Google Scholar]
  22. Galvan T., Camuso J., Sullivan K., Kim S., White D., Redline S., et al. (2017). Association of estradiol with sleep apnea in depressed perimenopausal and postmenopausal women: a preliminary study. Menopause 24 112–117. 10.1097/gme.0000000000000737 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gibson P. G., Vertigan A. E. (2009). Speech pathology for chronic cough: a new approach. Pulm. Pharmacol. Ther. 22 159–162. 10.1016/j.pupt.2008.11.005 [DOI] [PubMed] [Google Scholar]
  24. Gilliver S. C., Emmerson E., Bernhagen J., Hardman M. J. (2011). MIF: a key player in cutaneous biology and wound healing. Exp. Dermatol. 20 1–6. 10.1111/j.1600-0625.2010.01194.x [DOI] [PubMed] [Google Scholar]
  25. Grabowski M., Seys S., Decraene A., Kasran A., Dilissen E., Barg W., et al. (2013). Airway inflammation in patients with chronic non-asthmatic cough. Thorax 68 125–130. 10.1136/thoraxjnl-2012-201895 [DOI] [PubMed] [Google Scholar]
  26. Grishina I., Fenton A., Sankaran-Walters S. (2014). Gender differences, aging and hormonal status in mucosal injury and repair. Aging Dis. 5 160–169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Haldar P., Pavord I. D., Shaw D. E., Berry M. A., Thomas M., Brightling C. E., et al. (2008). Cluster analysis and clinical asthma phenotypes. Am. J. Respir. Crit. Care Med. 178 218–224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Hamano N., Terada N., Maesako K., Ikeda T., Fukuda S., Wakita J., et al. (1998a). Expression of histamine receptors in nasal epithelial cells and endothelial cells–the effects of sex hormones. Int. Arch. Allergy Immunol. 115 220–227. 10.1159/000023904 [DOI] [PubMed] [Google Scholar]
  29. Hamano N., Terada N., Maesako K., Numata T., Konno A. (1998b). Effect of sex hormones on eosinophilic inflammation in nasal mucosa. Allergy Asthma Proc. 19 263–269. 10.2500/108854198778557773 [DOI] [PubMed] [Google Scholar]
  30. Hartley N. A., Petty B. E., Johnson B., Thibeault S. L. (2015). Comparative analysis of clinical profile: chronic cough vs paradoxical vocal fold motion. Respir. Med. 109 1516–1520. 10.1016/j.rmed.2015.10.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Hilton E., Satia I., Holt K., Woodcock A. A., Belcher J., Smith J. A. (2020). The effect of pain conditioning on experimentally evoked cough: evidence of impaired endogenous inhibitory control mechanisms in refractory chronic cough. Eur. Respir. J. 56:2001387. 10.1183/13993003.01387-2020 [DOI] [PubMed] [Google Scholar]
  32. Irwin R. S. (2006). Complications of cough: ACCP evidence-based clinical practice guidelines. Chest 129(Suppl. 1) 54s–58s. [DOI] [PubMed] [Google Scholar]
  33. Irwin R. S., Ownbey R., Cagle P. T., Baker S., Fraire A. E. (2006). Interpreting the histopathology of chronic cough: a prospective, controlled, comparative study. Chest 130 362–370. 10.1378/chest.130.2.362 [DOI] [PubMed] [Google Scholar]
  34. Jensen-Jarolim E., Untersmayr E. (2008). Gender-medicine aspects in allergology. Allergy 63 610–615. 10.1111/j.1398-9995.2008.01645.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Kang S. Y., Won H. K., Lee S. M., Kwon J. W., Kim M. H., Jo E. J., et al. (2019). Impact of cough and unmet needs in chronic cough: a survey of patients in Korea. Lung 197 635–639. 10.1007/s00408-019-00258-9 [DOI] [PubMed] [Google Scholar]
  36. Kastelik J. A., Thompson R. H., Aziz I., Ojoo J. C., Redington A. E., Morice A. H. (2002). Sex-related differences in cough reflex sensitivity in patients with chronic cough. Am. J. Respir. Crit. Care Med. 166 961–964. 10.1164/rccm.2109061 [DOI] [PubMed] [Google Scholar]
  37. Kavalcikova-Bogdanova N., Buday T., Plevkova J., Song W. J. (2016). Chronic cough as a female gender issue. Adv. Exp. Med. Biol. 905 69–78. 10.1007/5584_2015_182 [DOI] [PubMed] [Google Scholar]
  38. Kavalcikova-Bogdanova N., Kovacikova L., Buday T., Biringer K., Sivakova J., Calkovsky V., et al. (2018). Sensitivity of airway cough-related afferents is influenced by female sex hormones. Respir. Physiol. Neurobiol. 257 12–17. 10.1016/j.resp.2018.01.006 [DOI] [PubMed] [Google Scholar]
  39. Kelsall A., Decalmer S., McGuinness K., Woodcock A., Smith J. A. (2009). Sex differences and predictors of objective cough frequency in chronic cough. Thorax 64 393–398. 10.1136/thx.2008.106237 [DOI] [PubMed] [Google Scholar]
  40. Kiasalari Z., Salehi I., Zhong Y., McMahon S. B., Michael-Titus A. T., Michael G. J. (2010). Identification of perineal sensory neurons activated by innocuous heat. J. Comp. Neurol. 518 137–162. 10.1002/cne.22187 [DOI] [PubMed] [Google Scholar]
  41. Kim Y. S., Kim N., Kim G. H. (2016). Sex and gender differences in gastroesophageal reflux disease. J. Neurogastroenterol. Motil. 22 575–588. 10.5056/jnm16138 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Lai K., Chen R., Lin J., Huang K., Shen H., Kong L., et al. (2013). A prospective, multicenter survey on causes of chronic cough in China. Chest 143 613–620. 10.1378/chest.12-0441 [DOI] [PubMed] [Google Scholar]
  43. Lai K., Long L. (2020). Current status and future directions of chronic cough in China. Lung 198 23–29. 10.1007/s00408-019-00319-z [DOI] [PubMed] [Google Scholar]
  44. Lai K., Long L., Yi F., Tang J., Chen Z., Chen F., et al. (2019). Age and sex distribution of Chinese chronic cough patients and their relationship with capsaicin cough sensitivity. Allergy Asthma Immunol. Res. 11 871–884. 10.4168/aair.2019.11.6.871 [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Lefaudeux D., de Meulder B., Loza M. J., Peffer N., Rowe A., Baribaud F., et al. (2017). U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics. J. Allergy Clin. Immunol. 139 1797–1807. [DOI] [PubMed] [Google Scholar]
  46. Liang S., Xu X., Qiu Z. (2012). Obstructive sleep apnea-hypopnea syndrome and chronic cough. Int. J. Respir. 32 1031–1034. [Google Scholar]
  47. Lim L. H., Wagner E. M. (2003). Airway distension promotes leukocyte recruitment in rat tracheal circulation. Am. J. Respir. Crit. Care Med. 168 1068–1074. 10.1164/rccm.200207-690oc [DOI] [PubMed] [Google Scholar]
  48. Liu G. L., Lin J. T. (2009). The spectrum and clinical features of causes for chronic cough. Chin. J. Tuberc. Respir. Dis. 32 422–425. [PubMed] [Google Scholar]
  49. Liu W. Y., Yu Q., Yue H. M., Zhang J. B., Li L., Wang X. Y., et al. (2016). The distribution characteristics of etiology of chronic cough in Lanzhou. Chin. J. Tuberc. Respir. Dis. 39 362–367. [DOI] [PubMed] [Google Scholar]
  50. Long L., Yao H., Tian J., Luo W., Yu X., Yi F., et al. (2019). Heterogeneity of cough hypersensitivity mediated by TRPV1 and TRPA1 in patients with chronic refractory cough. Respir. Res. 20:112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Ma B., Yu L. H., Fan J., Cong B., He P., Ni X., et al. (2011). Estrogen modulation of peripheral pain signal transduction: involvement of P2X(3) receptors. Purinergic Signal. 7 73–83. 10.1007/s11302-010-9212-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Ma W., Qiu Z. (2008). Evaluation on quality of life for chronic cough. Int. J. Respir. 28 187–189. [Google Scholar]
  53. Ma W., Yu L., Wang Y., Li X., Lü H., Qiu Z. (2009). Changes in health-related quality of life and clinical implications in Chinese patients with chronic cough. Cough 5:7. 10.1186/1745-9974-5-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Masaka T., Iijima K., Endo H., Asanuma K., Ara N., Ishiyama F., et al. (2013). Gender differences in oesophageal mucosal injury in a reflux oesophagitis model of rats. Gut 62 6–14. 10.1136/gutjnl-2011-301389 [DOI] [PubMed] [Google Scholar]
  55. Mazzone S. B. (2019). Chronic cough: a disorder of response inhibition? Eur. Respir. J. 53:1900254. 10.1183/13993003.00254-2019 [DOI] [PubMed] [Google Scholar]
  56. Mazzone S. B., McGovern A. E., Yang S. K., Woo A., Phipps S., Ando A., et al. (2013). Sensorimotor circuitry involved in the higher brain control of coughing. Cough 9:7. 10.1186/1745-9974-9-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Menon S., Jayasena H., Nightingale P., Trudgill N. J. (2011). Influence of age and sex on endoscopic findings of gastrooesophageal reflux disease: an endoscopy database study. Eur. J. Gastroenterol. Hepatol. 23 389–395. 10.1097/meg.0b013e328345d429 [DOI] [PubMed] [Google Scholar]
  58. Mitchell J. E., Campbell A. P., New N. E., Sadofsky L. R., Kastelik J. A., Mulrennan S. A., et al. (2005). Expression and characterization of the intracellular vanilloid receptor (TRPV1) in bronchi from patients with chronic cough. Exp. Lung Res. 31 295–306. 10.1080/01902140590918803 [DOI] [PubMed] [Google Scholar]
  59. Moore W. C., Meyers D. A., Wenzel S. E., Teague W. G., Li H., Li X., et al. (2010). Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am. J. Respir. Crit. Care Med. 181 315–323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Morice A. H. (2010). The cough hypersensitivity syndrome: a novel paradigm for understanding cough. Lung 188(Suppl. 1) S87–S90. [DOI] [PubMed] [Google Scholar]
  61. Morice A. H. (2013). Chronic cough hypersensitivity syndrome. Cough 9:14. 10.1186/1745-9974-9-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Morice A. H., Geppetti P. (2004). Cough. 5: the type 1 vanilloid receptor: a sensory receptor for cough. Thorax 59 257–258. 10.1136/thx.2003.013482 [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Morice A. H., Jakes A. D., Faruqi S., Birring S. S., McGarvey L., Canning B., et al. (2014). A worldwide survey of chronic cough: a manifestation of enhanced somatosensory response. Eur. Respir. J. 44 1149–1155. 10.1183/09031936.00217813 [DOI] [PubMed] [Google Scholar]
  64. Muccino D. R., Morice A. H., Birring S. S., Dicpinigaitis P. V., Pavord I. D., Assaid C., et al. (2020). Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough. ERJ Open Res. 6 00284–2020. 10.1183/23120541.00284-2020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Niimi A., Ohbayashi H., Sagara H., Yamauchi K., Akiyama K., Takahashi K., et al. (2013). Cough variant and cough-predominant asthma are major causes of persistent cough: a multicenter study in Japan. J. Asthma 50 932–937. 10.3109/02770903.2013.823444 [DOI] [PubMed] [Google Scholar]
  66. O’Neill J., McMahon S. B., Undem B. J. (2013). Chronic cough and pain: Janus faces in sensory neurobiology? Pulm. Pharmacol. Ther. 26 476–485. 10.1016/j.pupt.2013.06.010 [DOI] [PubMed] [Google Scholar]
  67. Patberg K. W. (2011). The female preponderance to cough hypersensitivity syndrome: another clue pointing to the role of TRPV1 in cough. Lung 189 257–258. 10.1007/s00408-011-9295-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Peng H. Y., Huang P. C., Liao J. M., Tung K. C., Lee S. D., Cheng C. L., et al. (2008). Estrous cycle variation of TRPV1-mediated cross-organ sensitization between uterus and NMDA-dependent pelvic-urethra reflex activity. Am. J. Physiol. Endocrinol. Metab. 295 E559–E568. [DOI] [PubMed] [Google Scholar]
  69. Pohóczky K., Kun J., Szalontai B., Szöke É, Sághy É, Payrits M., et al. (2016). Estrogen-dependent up-regulation of TRPA1 and TRPV1 receptor proteins in the rat endometrium. J. Mol. Endocrinol. 56 135–149. 10.1530/jme-15-0184 [DOI] [PubMed] [Google Scholar]
  70. Ricciardolo F. L. (2001). Mechanisms of citric acid-induced bronchoconstriction. Am. J. Med. 111(Suppl. 8A) 18S–24S. [DOI] [PubMed] [Google Scholar]
  71. Ryan N. M., Birring S. S., Gibson P. G. (2012). Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Lancet 380 1583–1589. 10.1016/s0140-6736(12)60776-4 [DOI] [PubMed] [Google Scholar]
  72. Ryan N. M., Vertigan A. E., Gibson P. G. (2009). Chronic cough and laryngeal dysfunction improve with specific treatment of cough and paradoxical vocal fold movement. Cough 5:4. 10.1186/1745-9974-5-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Shahar E., Redline S., Young T., Boland L. L., Baldwin C. M., Nieto F. J., et al. (2003). Hormone replacement therapy and sleep-disordered breathing. Am. J. Respir. Crit. Care Med. 167 1186–1192. [DOI] [PubMed] [Google Scholar]
  74. Shi C., Liang S., Xu X., Chen Q., Wang L., Yu L., et al. (2019). Cough hypersensitivity in patients with obstructive sleep apnea hypopnea syndrome. Sleep Breath. 23 33–39. [DOI] [PubMed] [Google Scholar]
  75. Shi C., Qiu Z. (2007). Effect of ajrway inflammation on chronic cough. Int. J. Respir. 27 773–776. [Google Scholar]
  76. Smith J. A., Kitt M. M., Morice A. H., Birring S. S., McGarvey L. P., Sher M. R., et al. (2020). Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial. Lancet Respir. Med. 8 775–785. [DOI] [PubMed] [Google Scholar]
  77. Smith M. T., Jr., Remeniuk B., Finan P. H., Speed T. J., Tompkins D. A., Robinson M., et al. (2019). Sex differences in measures of central sensitization and pain sensitivity to experimental sleep disruption: implications for sex differences in chronic pain. Sleep 42:zsy209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Song W. J., Chang Y. S., Faruqi S., Kim J. Y., Kang M. G., Kim S., et al. (2015). The global epidemiology of chronic cough in adults: a systematic review and meta-analysis. Eur. Respir. J. 45 1479–1481. 10.1183/09031936.00218714 [DOI] [PubMed] [Google Scholar]
  79. Song W. J., Kim J. Y., Jo E. J., Lee S. E., Kim M. H., Yang M. S., et al. (2014). Capsaicin cough sensitivity is related to the older female predominant feature in chronic cough patients. Allergy Asthma Immunol. Res. 6 401–408. 10.4168/aair.2014.6.5.401 [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Sorge R. E., Totsch S. K. (2017). Sex differences in pain. J. Neurosci. Res. 95 1271–1281. [DOI] [PubMed] [Google Scholar]
  81. Sterusky M., Plevkova J., Grendar M., Buday T. (2020). Female guinea pig model for cough studies and its response to most common tussive substances. Physiol. Res. 69(Suppl. 1) S171–S179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Vega K. J., Langford-Legg T., Palacio C., Watts J., Jamal M. M. (2013). Females without reflux symptoms or gastroesophageal reflux disease have less distal esophageal acid exposure than males without reflux symptoms or gastroesophageal reflux disease. Dis. Esophagus 26 246–249. 10.1111/j.1442-2050.2012.01367.x [DOI] [PubMed] [Google Scholar]
  83. Wang Y., Yu L., Qiu Z. (2010). Pathogenesis, diagnosis and treatment of gastroesophageal reflux-related chronic cough. Int. J. Respir. 30 418–421. [Google Scholar]
  84. Won H. K., Lee J. H., An J., Sohn K. H., Kang M. G., Kang S. Y., et al. (2020). Impact of chronic cough on health-related quality of life in the Korean adult general population: the Korean National Health and Nutrition Examination Survey 2010-2016. Allergy Asthma Immunol. Res. 12 964–979. 10.4168/aair.2020.12.6.964 [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Woolf C. J., Salter M. W. (2000). Neuronal plasticity: increasing the gain in pain. Science 288 1765–1769. 10.1126/science.288.5472.1765 [DOI] [PubMed] [Google Scholar]
  86. Xu S., Cheng Y., Keast J. R., Osborne P. B. (2008). 17beta-estradiol activates estrogen receptor beta-signalling and inhibits transient receptor potential vanilloid receptor 1 activation by capsaicin in adult rat nociceptor neurons. Endocrinology 149 5540–5548. 10.1210/en.2008-0278 [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Yang C., Chen R., Li B., Wang F., Lai K. (2010). Survey of quality of life and incontinence in female patients with chronic cough. Int. J. Respir. 30 391–394. [Google Scholar]
  88. Young E. C., Smith J. A. (2010). Quality of life in patients with chronic cough. Ther. Adv. Respir. Dis. 4 49–55. [DOI] [PubMed] [Google Scholar]
  89. Yu L., Chen Q., Qiu Z. (2016). Diagnosis and treatment of refractory cough. Chin. J. Tuberc. Respir. Dis. 39 383–386. [DOI] [PubMed] [Google Scholar]
  90. Yu L., Wei W. L., Lü H. J., Qiu Z. M. (2009). Changes in the spectrum and frequency of causes for chronic cough: a retrospective analysis. Chin. J. Tuberc. Respir. Dis. 32 414–417. [PubMed] [Google Scholar]

Articles from Frontiers in Physiology are provided here courtesy of Frontiers Media SA

RESOURCES